Tasly Pharmaceutical Group Co. Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 1,764.089 million compared to CNY 3,952.806 million a year ago. Operating income was CNY 380.068 million compared to CNY 366.776 million a year ago. Net income was CNY 322.964 million compared to CNY 294.865 million a year ago. Basic earnings per share from continuing operations was CNY 0.2149 compared to CNY 0.1955 a year ago.